Page 5 - Pillar Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pillar biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pillar Biosciences Today - Breaking & Trending Today

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an . ....

Randy Prichard , Amy Yoder , Beckman Coulter Life Sciences , Pillar Biosciences , Genomics Product , Next Generation Sequencing , Google Chrome , Microsoft Edge Enabled , Dynamic Deckoptix ,

AffyImmune Therapeutics Adds Serial Entrepreneur Robert Forrester to Board of Directors

/PRNewswire/ AffyImmune Therapeutics, Inc., a clinical stage biotechnology company using its Tune & Track platform to develop CAR T cells for the treatment. ....

United Kingdom , City Of , Brixton Biosciences , Robert Forrester , Matt Britz , University Of Law Guildford , Prnewswire Affyimmune Therapeutics Inc , Affyimmune Therapeutics Inc , University Of Bristol , Aimmune Therapeutics , Simone Song , Affyimmune President Matt , Pillar Biosciences , Law Guildford , Affyimmune Therapeutics ,

Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay

The OncoReveal Dx Colon Cancer Assay is intended for use on the Illumina MiSeq Dx, and now has approvals in China, the US, and Europe. ....

United States , Eli Lilly Erbitux , Randy Pritchard , Amgen Vectibix , China National Medical Products Administration , Drug Administration , Pillar Biosciences , National Medical Products Administration , Oncoreveal Dx Colon Cancer , Eli Lilly , Oncoreveal Dx Lung , Colon Cancer ,

BIS Research Study Highlights the Global NGS Oncology Market to Reach $51.78 Billion by 2032

/PRNewswire/ The global NGS oncology market is projected to reach $51.78 billion in terms of revenue by 2032, at a CAGR of 12.04%, suggests the premium. ....

United States , Nitish Kumar Singh , Integragen Onco , Pacific Biosciences , Agilent Technologies Inc , Perkinelmer Inc , California Inc , Invitae Corporation , Digital Health , Fulgent Genetics Inc , Takara Bio Inc , Information Technology , Pillar Biosciences Inc , Research Inc , Roche Ltd , Biodesix Inc , Bio Rad Laboratories Inc , Key Companies , Research Related Market , Life Sciences , Illumina Inc , Thermo Fisher Scientific Inc , Caris Life Sciences , Analysis And Forecast , Increasing Incidence , Cancer Requiring Sophisticated Molecular ,

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Hong Kong International Airport , Hong Kong General , South Korea , Cheng Yuet Ngor , Zhitong Caijing , Zhao Weili , Li Jianyong , National Radiation Therapy , China Biotech Service , College Of American Pathologists , Town Health International , Sunrise Diagnostic Center , Pillar Biosciences Inc , National Medical Products Administration Of China , Asia Molecular Diagnostic Laboratory , Stock Exchange Of Hong Kong , Chinese Medical Association , China Biotech Services , National Reimbursement Drug List , Hong Kong Science Technology Park , National Radiotherapy Survey , Hospital Of Xuzhou Medical University , Shenzhen Bay Port , Kong Port ,